BriaCell Therapeutics Corp
BioTech/Drugs - Philadelphia, PA, US
BriaCell Therapeutics Corp Employees
BriaCell Therapeutics Corp Senior Management
BriaCell Therapeutics Corp Details
ABOUT BRIACELLBriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V:BCT) is a clinical-stage biotechnology company specializing in targeted immunotherapies for cancer. BriaCell achieved positive proof-of-concept in a Phase I/IIa clinical trial for Bria-IMT™ in patients with advanced breast cancer. BriaCell is conducting a Phase I/IIa clinical trial of Bria-IMT™ in a combination with retifanlimab and epacadostat (both provided by Incyte under a collaboration agreement). Additionally, BriaCell is developing Bria-OTS™, the first "off the shelf" personalized immunotherapy for advanced breast cancer. For additional information on BriaCell, please visit our website: http://briacell.com/
BriaCell Therapeutics Corp Technologies
Email Providers
Outlook
Widgets
Facebook Widget
Tag Management
Google Tag Manager
Advertising Networks
Linkedin Marketing Solutions
Other
Microsoft Office 365
Online Video Platforms
Wistia